Pharmacy Benefit Manager Accountability Study Act of 2021
Summary
Pharmacy Benefit Manager Accountability Study Act of 2021 This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit managers.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2021
Committee Review
Floor Vote
President
Introduced Mar 11, 2021
Last action Mar 12, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Mar 12, 2021
Committee
Referred to the Subcommittee on Health.
lower
Mar 11, 2021
Committee
Referred to the House Committee on Energy and Commerce.
lower
Mar 11, 2021
Introduced
Introduced in House
lower
1 primary · 29 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Diana Harshbarger
RRepublican
Co
Ben Cline
RRepublican
Co
Bill Posey
RRepublican
Co
Burgess Owens
RRepublican
Co
Cynthia Axne
DDemocratic
Co
Dean Phillips
DDemocratic
Co
Earl L. "Buddy" Carter
RRepublican
Co
Fred Keller
RRepublican
Co
Glenn Grothman
RRepublican
Co
Glenn Thompson
RRepublican
Co
Gregory F. Murphy
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 1829
Scope: US
Hi! I can help you understand HR 1829. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline